Paper Details
- Home
- Paper Details
Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: an immunohistochemical study.
Author: OteroMarisol E, PaschMarcel C, de Boer-van HuizenRoelie T, van ErpPiet E J, van LingenRosanne G, van de KerkhofPeter C M, van der VeldenHaike M J
Original Abstract of the Article :
The combination of calcipotriol (Cp) and topical corticosteroids increases efficacy and reduces side effects as compared to monotherapies. Previous studies suggest that such combinations may have an added value with respect to reduction of T-cell subsets. A two-compound product consisting of Cp and ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.3109/09546630903214175
データ提供：米国国立医学図書館（NLM）
Calcipotriol/Betamethasone Dipropionate: A Two-Pronged Approach to Plaque Psoriasis
Plaque psoriasis, a chronic inflammatory skin condition, can significantly impact quality of life. This study investigates the efficacy of a two-compound topical treatment, calcipotriol/betamethasone dipropionate, in managing plaque psoriasis. Utilizing [research methods], the researchers compared the effects of this combination therapy to those of monotherapy with either calcipotriol or betamethasone dipropionate. Their findings suggest that the combination therapy may offer a more effective and targeted approach to managing plaque psoriasis.
A Combined Effort: Calcipotriol/Betamethasone Dipropionate Excels in Plaque Psoriasis Management
The study reveals that the combination therapy outperforms both monotherapies in managing plaque psoriasis. The researchers observed a more pronounced reduction in epidermal and dermal T-cell markers and human beta defensin-2 following combination treatment. These findings suggest that the combination therapy may effectively target multiple pathways involved in psoriasis pathogenesis, leading to a more comprehensive and effective treatment outcome.
A New Oasis in the Desert of Psoriasis: Calcipotriol/Betamethasone Dipropionate Offers Hope
The study's findings offer a beacon of hope for individuals seeking to manage their plaque psoriasis. The research suggests that calcipotriol/betamethasone dipropionate may provide a more effective and targeted treatment option compared to monotherapies. This research is a valuable step forward in the ongoing pursuit of improved therapies for plaque psoriasis.
Dr. Camel's Conclusion
This study highlights the potential benefits of a two-compound topical treatment, calcipotriol/betamethasone dipropionate, for managing plaque psoriasis. The research suggests that this combination therapy may offer a more effective and targeted approach to managing the condition, providing a potential oasis of relief in the desert of discomfort.
Date :
- Date Completed 2010-10-14
- Date Revised 2015-11-19
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.